With the goal of cutting cancer deaths in half by 2047, the White House's Cancer Moonshot initiative is pumping $1.8 billion into cancer research over the next seven years. Achieving this goal, however, will require clearing research hurdles — including the lack of diversity in clinical trials, say Richard Barakat, MD, and David Tuveson, MD, PhD. They discuss the exciting research being funded by the Moonshot initiative, describe efforts to improve and diversify clinical trial recruitment, and explain the fruitful collaboration between Northwell Health and Cold Spring Harbor.Chapters:Meet the expertsRichard Barakat, MD, Physician-in-Chief and Director of Cancer, Northwell Cancer InstituteDavid Tuveson, MD, PhD, Professor, Director, Cancer Center, Cold Spring HarborWatch episodes of 20-Minute Health Talk on YouTube.